Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial

Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective. Th...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of obstetrics and gynecology Vol. 222; no. 3; pp. 249.e1 - 249.e10
Main Authors Obermair, Andreas, Asher, Rebecca, Pareja, Rene, Frumovitz, Michael, Lopez, Aldo, Moretti-Marques, Renato, Rendon, Gabriel, Ribeiro, Reitan, Tsunoda, Audrey, Behan, Vanessa, Buda, Alessandro, Bernadini, Marcus Q., Zhao, Hongqin, Vieira, Marcelo, Walker, Joan, Spirtos, Nick M., Yao, Shuzhong, Chetty, Naven, Zhu, Tao, Isla, David, Tamura, Mariano, Nicklin, James, Robledo, Kristy P., Gebski, Val, Coleman, Robert L., Salvo, Gloria, Ramirez, Pedro T.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2020
Subjects
Online AccessGet full text
ISSN0002-9378
1097-6868
1085-8709
1097-6868
DOI10.1016/j.ajog.2019.09.036

Cover

Abstract Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective. The purpose of this study was to compare the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer. The Laparoscopic Approach to Carcinoma of the Cervix trial was a multinational, randomized noninferiority trial that was conducted between 2008 and 2017, in which surgeons from 33 tertiary gynecologic cancer centers in 24 countries randomly assigned 631 women with International Federation of Gynecology and Obstetrics 2009 stage IA1 with lymph-vascular invasion to IB1 cervical cancer to undergo minimally invasive (n = 319) or open radical hysterectomy (n = 312). The Laparoscopic Approach to Carcinoma of the Cervix trial was suspended for enrolment in September 2017 because of an increased risk of recurrence and death in the minimally invasive surgery group. Here we report on a secondary outcome measure: the incidence of intra- and postoperative adverse events within 6 months after surgery. Of 631 randomly assigned patients, 536 (85%; mean age, 46.0 years) met inclusion criteria for this analysis; 279 (52%) underwent minimally invasive radical hysterectomy, and 257 (48%) underwent open radical hysterectomy. Of those, 300 (56%), 91 (16.9%), and 69 (12.8%) experienced at least 1 grade ≥2 or ≥3 or a serious adverse event, respectively. The incidence of intraoperative grade ≥2 adverse events was 12% (34/279 patients) in the minimally invasive group vs 10% (26/257) in the open group (difference, 2.1%; 95% confidence interval, –3.3 to 7.4%; P=.45). The overall incidence of postoperative grade ≥2 adverse events was 54% (152/279 patients) in the minimally invasive group vs 48% (124/257) in the open group (difference, 6.2%; 95% confidence interval, –2.2 to 14.7%; P=.14). For early cervical cancer, the use of minimally invasive compared with open radical hysterectomy resulted in a similar overall incidence of intraoperative or postoperative adverse events.
AbstractList Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective. The purpose of this study was to compare the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer. The Laparoscopic Approach to Carcinoma of the Cervix trial was a multinational, randomized noninferiority trial that was conducted between 2008 and 2017, in which surgeons from 33 tertiary gynecologic cancer centers in 24 countries randomly assigned 631 women with International Federation of Gynecology and Obstetrics 2009 stage IA1 with lymph-vascular invasion to IB1 cervical cancer to undergo minimally invasive (n = 319) or open radical hysterectomy (n = 312). The Laparoscopic Approach to Carcinoma of the Cervix trial was suspended for enrolment in September 2017 because of an increased risk of recurrence and death in the minimally invasive surgery group. Here we report on a secondary outcome measure: the incidence of intra- and postoperative adverse events within 6 months after surgery. Of 631 randomly assigned patients, 536 (85%; mean age, 46.0 years) met inclusion criteria for this analysis; 279 (52%) underwent minimally invasive radical hysterectomy, and 257 (48%) underwent open radical hysterectomy. Of those, 300 (56%), 91 (16.9%), and 69 (12.8%) experienced at least 1 grade ≥2 or ≥3 or a serious adverse event, respectively. The incidence of intraoperative grade ≥2 adverse events was 12% (34/279 patients) in the minimally invasive group vs 10% (26/257) in the open group (difference, 2.1%; 95% confidence interval, –3.3 to 7.4%; P=.45). The overall incidence of postoperative grade ≥2 adverse events was 54% (152/279 patients) in the minimally invasive group vs 48% (124/257) in the open group (difference, 6.2%; 95% confidence interval, –2.2 to 14.7%; P=.14). For early cervical cancer, the use of minimally invasive compared with open radical hysterectomy resulted in a similar overall incidence of intraoperative or postoperative adverse events.
Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective.BACKGROUNDStandard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer is either nonrandomized or retrospective.The purpose of this study was to compare the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer.OBJECTIVEThe purpose of this study was to compare the incidence of adverse events after minimally invasive vs open radical hysterectomy for early cervical cancer.The Laparoscopic Approach to Carcinoma of the Cervix trial was a multinational, randomized noninferiority trial that was conducted between 2008 and 2017, in which surgeons from 33 tertiary gynecologic cancer centers in 24 countries randomly assigned 631 women with International Federation of Gynecology and Obstetrics 2009 stage IA1 with lymph-vascular invasion to IB1 cervical cancer to undergo minimally invasive (n = 319) or open radical hysterectomy (n = 312). The Laparoscopic Approach to Carcinoma of the Cervix trial was suspended for enrolment in September 2017 because of an increased risk of recurrence and death in the minimally invasive surgery group. Here we report on a secondary outcome measure: the incidence of intra- and postoperative adverse events within 6 months after surgery.STUDY DESIGNThe Laparoscopic Approach to Carcinoma of the Cervix trial was a multinational, randomized noninferiority trial that was conducted between 2008 and 2017, in which surgeons from 33 tertiary gynecologic cancer centers in 24 countries randomly assigned 631 women with International Federation of Gynecology and Obstetrics 2009 stage IA1 with lymph-vascular invasion to IB1 cervical cancer to undergo minimally invasive (n = 319) or open radical hysterectomy (n = 312). The Laparoscopic Approach to Carcinoma of the Cervix trial was suspended for enrolment in September 2017 because of an increased risk of recurrence and death in the minimally invasive surgery group. Here we report on a secondary outcome measure: the incidence of intra- and postoperative adverse events within 6 months after surgery.Of 631 randomly assigned patients, 536 (85%; mean age, 46.0 years) met inclusion criteria for this analysis; 279 (52%) underwent minimally invasive radical hysterectomy, and 257 (48%) underwent open radical hysterectomy. Of those, 300 (56%), 91 (16.9%), and 69 (12.8%) experienced at least 1 grade ≥2 or ≥3 or a serious adverse event, respectively. The incidence of intraoperative grade ≥2 adverse events was 12% (34/279 patients) in the minimally invasive group vs 10% (26/257) in the open group (difference, 2.1%; 95% confidence interval, -3.3 to 7.4%; P=.45). The overall incidence of postoperative grade ≥2 adverse events was 54% (152/279 patients) in the minimally invasive group vs 48% (124/257) in the open group (difference, 6.2%; 95% confidence interval, -2.2 to 14.7%; P=.14).RESULTSOf 631 randomly assigned patients, 536 (85%; mean age, 46.0 years) met inclusion criteria for this analysis; 279 (52%) underwent minimally invasive radical hysterectomy, and 257 (48%) underwent open radical hysterectomy. Of those, 300 (56%), 91 (16.9%), and 69 (12.8%) experienced at least 1 grade ≥2 or ≥3 or a serious adverse event, respectively. The incidence of intraoperative grade ≥2 adverse events was 12% (34/279 patients) in the minimally invasive group vs 10% (26/257) in the open group (difference, 2.1%; 95% confidence interval, -3.3 to 7.4%; P=.45). The overall incidence of postoperative grade ≥2 adverse events was 54% (152/279 patients) in the minimally invasive group vs 48% (124/257) in the open group (difference, 6.2%; 95% confidence interval, -2.2 to 14.7%; P=.14).For early cervical cancer, the use of minimally invasive compared with open radical hysterectomy resulted in a similar overall incidence of intraoperative or postoperative adverse events.CONCLUSIONFor early cervical cancer, the use of minimally invasive compared with open radical hysterectomy resulted in a similar overall incidence of intraoperative or postoperative adverse events.
Author Vieira, Marcelo
Buda, Alessandro
Frumovitz, Michael
Zhao, Hongqin
Coleman, Robert L.
Asher, Rebecca
Obermair, Andreas
Chetty, Naven
Zhu, Tao
Nicklin, James
Yao, Shuzhong
Tsunoda, Audrey
Lopez, Aldo
Robledo, Kristy P.
Ramirez, Pedro T.
Gebski, Val
Bernadini, Marcus Q.
Walker, Joan
Tamura, Mariano
Pareja, Rene
Spirtos, Nick M.
Moretti-Marques, Renato
Behan, Vanessa
Ribeiro, Reitan
Isla, David
Salvo, Gloria
Rendon, Gabriel
Author_xml – sequence: 1
  givenname: Andreas
  surname: Obermair
  fullname: Obermair, Andreas
  email: Obermair@powerup.com.au
  organization: Queensland Centre for Gynaecological Cancer Research, University of Queensland, Centre for Clinical Research, RBWH, Herston, QLD Australia
– sequence: 2
  givenname: Rebecca
  surname: Asher
  fullname: Asher, Rebecca
  organization: National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW Australia
– sequence: 3
  givenname: Rene
  surname: Pareja
  fullname: Pareja, Rene
  organization: Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá and Clínica de Oncología Astorga, Medellín, Colombia
– sequence: 4
  givenname: Michael
  surname: Frumovitz
  fullname: Frumovitz, Michael
  organization: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
– sequence: 5
  givenname: Aldo
  surname: Lopez
  fullname: Lopez, Aldo
  organization: Department of Gynecologic Surgery, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
– sequence: 6
  givenname: Renato
  surname: Moretti-Marques
  fullname: Moretti-Marques, Renato
  organization: Gynecologic Oncology Division, Oncologic Center, Hospital Israelita Albert Einstein, São Paulo-SP, Brazil
– sequence: 7
  givenname: Gabriel
  orcidid: 0000-0002-7536-0567
  surname: Rendon
  fullname: Rendon, Gabriel
  organization: Instituto de Cancerologia–Las Americas, Medellín, Colombia
– sequence: 8
  givenname: Reitan
  surname: Ribeiro
  fullname: Ribeiro, Reitan
  organization: Department of Surgery, Erasto Gaertner Hospital, Curitiba, Brazil
– sequence: 9
  givenname: Audrey
  surname: Tsunoda
  fullname: Tsunoda, Audrey
  organization: Department of Surgery, Erasto Gaertner Hospital, Curitiba, Brazil
– sequence: 10
  givenname: Vanessa
  surname: Behan
  fullname: Behan, Vanessa
  organization: Queensland Centre for Gynaecological Cancer Research, University of Queensland, Centre for Clinical Research, RBWH, Herston, QLD Australia
– sequence: 11
  givenname: Alessandro
  surname: Buda
  fullname: Buda, Alessandro
  organization: Unit of Gynecologic Oncology Surgery, Department of Obstetrics and Gynecology, San Gerardo Hospital, Monza MB, Italy
– sequence: 12
  givenname: Marcus Q.
  orcidid: 0000-0001-7022-8308
  surname: Bernadini
  fullname: Bernadini, Marcus Q.
  organization: Department of Gynecologic Oncology, Princess Margaret Cancer Center, Ontario, Canada
– sequence: 13
  givenname: Hongqin
  surname: Zhao
  fullname: Zhao, Hongqin
  organization: Department of Gynecology, First Affiliated Hospital of Wenzhou Medical College, Ouhai, Wenzhou, China
– sequence: 14
  givenname: Marcelo
  surname: Vieira
  fullname: Vieira, Marcelo
  organization: Department of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, Brazil
– sequence: 15
  givenname: Joan
  surname: Walker
  fullname: Walker, Joan
  organization: Department of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma, Norman, OK
– sequence: 16
  givenname: Nick M.
  surname: Spirtos
  fullname: Spirtos, Nick M.
  organization: Division of Gynecologic Oncology, Women’s Cancer Center of Nevada, LV
– sequence: 17
  givenname: Shuzhong
  surname: Yao
  fullname: Yao, Shuzhong
  organization: Department of Obstetrics and Gynecology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
– sequence: 18
  givenname: Naven
  surname: Chetty
  fullname: Chetty, Naven
  organization: Department of Gynecologic Oncology, Mater Health Services Brisbane, South Brisbane, QLD, Australia
– sequence: 19
  givenname: Tao
  surname: Zhu
  fullname: Zhu, Tao
  organization: Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China
– sequence: 20
  givenname: David
  surname: Isla
  fullname: Isla, David
  organization: Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Mexico
– sequence: 21
  givenname: Mariano
  surname: Tamura
  fullname: Tamura, Mariano
  organization: Gynecologic Oncology Division, Oncologic Center, Hospital Israelita Albert Einstein, São Paulo-SP, Brazil
– sequence: 22
  givenname: James
  surname: Nicklin
  fullname: Nicklin, James
  organization: Department of Gynaecologic Oncology, Royal Brisbane and Women’s Hospital and The University of Queensland, Brisbane, QLD, Australia
– sequence: 23
  givenname: Kristy P.
  surname: Robledo
  fullname: Robledo, Kristy P.
  organization: National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW Australia
– sequence: 24
  givenname: Val
  surname: Gebski
  fullname: Gebski, Val
  organization: National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Sydney, NSW Australia
– sequence: 25
  givenname: Robert L.
  surname: Coleman
  fullname: Coleman, Robert L.
  organization: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
– sequence: 26
  givenname: Gloria
  orcidid: 0000-0002-1753-1778
  surname: Salvo
  fullname: Salvo, Gloria
  organization: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
– sequence: 27
  givenname: Pedro T.
  surname: Ramirez
  fullname: Ramirez, Pedro T.
  organization: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31586602$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1vFSEUhompsbfVP-DCsHQzVz46DNO4MY0fTZq40TXhwhnlysAVZqYZ_4X_WPBWF11UExI44X0O57yHM3QSYgCEnlOypYSKV_ut3scvW0ZovyVlcfEIbSjpu0ZIIU_QhhDCmp538hSd5byvIevZE3TKaSuFIGyDfl4H4ywEAzgOWNsFUgYMC4QpYxfw6IIbtfdrCRad3QJ4yTgeIOCkrTPa469rniCBmeJYVRh0KnIDafl9bXRJni5xgjz7krQ-U9hg4-h-gMUmhilF78txSk77p-jxoH2GZ3f7Ofr87u2nqw_Nzcf311dvbhpz0dKpaaFl4sJSacxgaW92Oz2QTtBO81aI3dD20INogQvZUqG7noJkhvUDpYLwQfBzxI9553DQ623pUR1S6TWtihJVDVZ7VQ1W1WBFyuKVenmkDil-nyFPanTZgPc6QJyzYpxQKUXXVumLO-m8G8H-zf7H_CKQR4FJMecEgzJu0pOrhmjnHy6D3UP_q_bXRwiKrYuDpLJxdfTW1fEpG93D-OU93PjyO8qMv8H6L_gXfpDWZw
CitedBy_id crossref_primary_10_1007_s00432_024_05773_8
crossref_primary_10_1097_JS9_0000000000001980
crossref_primary_10_1016_j_ygyno_2021_10_073
crossref_primary_10_1186_s12885_024_13090_z
crossref_primary_10_3802_jgo_2024_35_e49
crossref_primary_10_3390_polym16081105
crossref_primary_10_1016_j_ejogrb_2022_06_004
crossref_primary_10_1007_s11701_024_01863_4
crossref_primary_10_3390_cancers14030575
crossref_primary_10_1016_j_tru_2021_100038
crossref_primary_10_1136_ijgc_2020_001663
crossref_primary_10_12677_ACM_2023_1371646
crossref_primary_10_1136_ijgc_2023_004657
crossref_primary_10_1186_s12893_024_02716_5
crossref_primary_10_3390_ijerph191811641
crossref_primary_10_3390_jcm13051496
crossref_primary_10_1016_j_fertnstert_2020_07_038
crossref_primary_10_1111_jog_15633
crossref_primary_10_1136_ijgc_2022_004092
crossref_primary_10_1016_j_bpobgyn_2023_102434
crossref_primary_10_1007_s11912_020_0876_1
crossref_primary_10_1136_ijgc_2020_001776
crossref_primary_10_1002_adhm_202302714
crossref_primary_10_3802_jgo_2024_35_e23
crossref_primary_10_1007_s00761_024_01560_9
crossref_primary_10_1177_10760296241240747
crossref_primary_10_3390_jcm13154351
crossref_primary_10_1111_iwj_13962
crossref_primary_10_1111_iwj_14535
crossref_primary_10_3390_diagnostics14050559
crossref_primary_10_1136_ijgc_2021_002577
crossref_primary_10_1002_ijgo_70028
crossref_primary_10_3390_jcm12175677
crossref_primary_10_1136_ijgc_2020_001406
crossref_primary_10_3802_jgo_2021_32_e10
crossref_primary_10_1186_s12885_022_10395_9
crossref_primary_10_1016_j_ijgc_2025_101760
crossref_primary_10_1186_s12893_024_02713_8
crossref_primary_10_1177_14574969231186283
crossref_primary_10_1097_AOG_0000000000005810
crossref_primary_10_4103_ijmr_IJMR_4240_20
crossref_primary_10_1007_s00404_021_06185_6
crossref_primary_10_1007_s10147_025_02735_z
crossref_primary_10_1186_s12957_023_03076_9
crossref_primary_10_1016_j_ygyno_2020_05_009
crossref_primary_10_1016_j_jogoh_2022_102364
crossref_primary_10_1016_j_jmig_2024_07_002
crossref_primary_10_3390_cancers14163863
crossref_primary_10_31260_RepertMedCir_01217372_1261
crossref_primary_10_1016_j_ejso_2024_108518
crossref_primary_10_1056_NEJMe2400423
crossref_primary_10_17816_aog643484
crossref_primary_10_1016_j_ajog_2024_08_008
crossref_primary_10_1002_ijgo_13141
crossref_primary_10_1007_s00129_022_04924_7
crossref_primary_10_1097_PGP_0000000000000735
crossref_primary_10_1016_j_asjsur_2022_06_141
crossref_primary_10_1136_ijgc_2021_003244
crossref_primary_10_1136_ijgc_2023_004593
crossref_primary_10_3390_diagnostics14242782
crossref_primary_10_1007_s11654_021_00294_z
crossref_primary_10_31083_j_ceog5002032
crossref_primary_10_1038_s41598_021_89071_0
crossref_primary_10_3389_fsurg_2025_1587048
crossref_primary_10_3390_curroncol29020093
crossref_primary_10_1016_j_ejso_2021_03_238
crossref_primary_10_7759_cureus_43035
crossref_primary_10_1016_j_jmig_2020_12_023
crossref_primary_10_1016_j_ygyno_2020_06_508
crossref_primary_10_1016_j_cca_2019_11_008
crossref_primary_10_1016_j_ygyno_2022_07_022
crossref_primary_10_3390_cancers16223806
crossref_primary_10_1097_RD9_0000000000000106
crossref_primary_10_1245_s10434_020_09265_0
crossref_primary_10_1016_j_ygyno_2021_05_028
crossref_primary_10_3389_fonc_2024_1404831
crossref_primary_10_1016_j_ygyno_2020_05_029
crossref_primary_10_3390_ijms23095134
crossref_primary_10_31083_j_ceog5002044
crossref_primary_10_1371_journal_pone_0253143
crossref_primary_10_1016_j_jmig_2022_03_014
crossref_primary_10_3390_cancers15051570
crossref_primary_10_1016_j_ygyno_2023_04_030
crossref_primary_10_1016_j_jogoh_2020_102031
crossref_primary_10_1016_j_jogoh_2020_101980
crossref_primary_10_1007_s00404_021_06248_8
crossref_primary_10_1111_aogs_14852
crossref_primary_10_3389_fendo_2023_1280631
crossref_primary_10_1007_s10815_021_02245_7
crossref_primary_10_1016_j_jmig_2022_05_021
crossref_primary_10_1155_ecc_9573736
crossref_primary_10_1111_1471_0528_17408
crossref_primary_10_3390_jcm10173761
crossref_primary_10_1007_s00404_020_05798_7
crossref_primary_10_1007_s00404_021_06082_y
crossref_primary_10_1136_ijgc_2022_003654
crossref_primary_10_1016_j_jmig_2024_12_009
crossref_primary_10_1136_ijgc_2020_001794
Cites_doi 10.1016/S0039-6109(05)70167-5
10.1016/j.ygyno.2006.10.033
10.1200/JCO.2009.22.3248
10.1089/lap.2017.0022
10.1016/j.ejso.2016.07.017
10.3322/caac.21551
10.1002/rcs.152
10.3322/caac.21492
10.1056/NEJMoa1806395
10.1016/j.jmig.2008.06.013
10.1016/j.ygyno.2015.06.009
10.1186/s12885-015-1818-4
10.1371/journal.pone.0193033
10.1089/lap.2015.0390
10.6004/jnccn.2019.0001
ContentType Journal Article
Copyright 2019
Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2019
– notice: Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
DOI 10.1016/j.ajog.2019.09.036
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6868
EndPage 249.e10
ExternalDocumentID oai:repositorio.inen.pe:INEN/130
31586602
10_1016_j_ajog_2019_09_036
S0002937819311652
Genre Clinical Trial, Phase III
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Cancer Institute
  grantid: P30CA016672
  funderid: https://doi.org/10.13039/100000054
– fundername: Department of Gynecologic Oncology and Reproductive Medicine
– fundername: The University of Texas MD Anderson Cancer Center
– fundername: NCI NIH HHS
  grantid: P30 CA016672
GroupedDBID ---
--K
--M
-ET
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1CY
1P~
1~.
1~5
23M
2KS
354
3O-
4.4
457
4CK
4G.
53G
5GY
5RE
5VS
6J9
7-5
85S
8F7
8P~
AAEDT
AAEDW
AAIKC
AAIKJ
AAKOC
AALRI
AAMNW
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYJJ
AAYWO
ABBQC
ABCQX
ABDPE
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABOCM
ABPMR
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFCHL
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGNAY
AGQPQ
AGUBO
AGYEJ
AHDLI
AI.
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
C5W
CAG
COF
CS3
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IH2
IHE
J1W
K-O
KOM
LPU
M41
MO0
N4W
N9A
NEJ
NQ-
O-L
O9-
OAUVE
OBH
OCB
OGEVE
OHH
OHT
OMK
OQ.
OVD
P-8
P-9
P2P
PC.
PH~
Q38
R2-
ROL
RPZ
RXW
SDF
SEL
SES
SEW
SJN
SPCBC
SSH
SSZ
T5K
TAE
TEORI
TWZ
UDS
UGJ
UHB
UHS
UHU
UKR
UNMZH
UV1
VH1
VVN
WH7
WOQ
WOW
X6Y
X7M
XFW
YFH
YOC
YYQ
YZZ
Z5R
ZGI
ZXP
ZY1
~G-
~H1
~HD
AACTN
AAIAV
ABLVK
ABYKQ
ADOJD
AFCTW
AFDAS
AFKWA
AHPSJ
AJBFU
AJOXV
AMFUW
G8K
LCYCR
NCXOZ
RIG
ZA5
AAYXX
CITATION
AGCQF
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c451t-5e5264d18ccfd19cbbaf07617a3566bf59e9e65e368516a791e82c29f11603f63
IEDL.DBID .~1
ISSN 0002-9378
1097-6868
1085-8709
IngestDate Sun Oct 26 03:18:38 EDT 2025
Sun Sep 28 08:32:27 EDT 2025
Mon Jul 21 06:01:20 EDT 2025
Wed Oct 01 03:54:37 EDT 2025
Thu Apr 24 22:59:49 EDT 2025
Fri Feb 23 02:50:29 EST 2024
Tue Oct 14 19:36:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords radical hysterectomy
complication
laparoscopic hysterectomy
robotic hysterectomy
minimally invasive surgery
LACC
hysterectomy
postoperative adverse event
cervical cancer
Language English
License Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved.
other-oa
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c451t-5e5264d18ccfd19cbbaf07617a3566bf59e9e65e368516a791e82c29f11603f63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-7536-0567
0000-0002-1753-1778
0000-0001-7022-8308
OpenAccessLink https://proxy.k.utb.cz/login?url=http://repositorio.inen.pe:8080/handle/INEN/130
PMID 31586602
PQID 2301886756
PQPubID 23479
ParticipantIDs unpaywall_primary_10_1016_j_ajog_2019_09_036
proquest_miscellaneous_2301886756
pubmed_primary_31586602
crossref_citationtrail_10_1016_j_ajog_2019_09_036
crossref_primary_10_1016_j_ajog_2019_09_036
elsevier_sciencedirect_doi_10_1016_j_ajog_2019_09_036
elsevier_clinicalkey_doi_10_1016_j_ajog_2019_09_036
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2020
2020-03-00
20200301
PublicationDateYYYYMMDD 2020-03-01
PublicationDate_xml – month: 03
  year: 2020
  text: March 2020
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle American journal of obstetrics and gynecology
PublicationTitleAlternate Am J Obstet Gynecol
PublicationYear 2020
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Koh, Abu-Rustum, Bean (bib3) 2019; 17
Shazly, Murad, Dowdy, Gostout, Famuyide (bib17) 2015; 138
Zhao, Hang, Xiong, Zhang (bib7) 2017; 27
Nevis, Vali, Higgins, Dhalla, Urbach, Bernardini (bib15) 2017; 11
Frumovitz, Ramirez (bib11) 2007; 104
Cao, Feng, Huang, Wan, Liu (bib5) 2015; 25
Wang, Deng, Xu, Zhang, Liang (bib6) 2015; 15
Jin, Liu, Chen, Chen, Ren (bib14) 2018; 13
Sert, Abeler (bib12) 2007; 3
Obermair, Gebski, Frumovitz (bib9) 2008; 15
Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (bib1) 2018; 68
Walker, Piedmonte, Spirtos (bib18) 2009; 27
(bib13) 2006
Siegel, Miller, Jemal (bib2) 2019; 69
Park, Yun, Kim, Lee (bib16) 2017; 43
Ramirez, Frumovitz, Pareja (bib8) 2018; 379
Piver, Rutledge (bib10) 1974; 44
Abu-Rustum, Hoskins (bib4) 2001; 81
Sert (10.1016/j.ajog.2019.09.036_bib12) 2007; 3
Piver (10.1016/j.ajog.2019.09.036_bib10) 1974; 44
Siegel (10.1016/j.ajog.2019.09.036_bib2) 2019; 69
Frumovitz (10.1016/j.ajog.2019.09.036_bib11) 2007; 104
Shazly (10.1016/j.ajog.2019.09.036_bib17) 2015; 138
Jin (10.1016/j.ajog.2019.09.036_bib14) 2018; 13
Koh (10.1016/j.ajog.2019.09.036_bib3) 2019; 17
Obermair (10.1016/j.ajog.2019.09.036_bib9) 2008; 15
Abu-Rustum (10.1016/j.ajog.2019.09.036_bib4) 2001; 81
(10.1016/j.ajog.2019.09.036_bib13) 2006
Bray (10.1016/j.ajog.2019.09.036_bib1) 2018; 68
Ramirez (10.1016/j.ajog.2019.09.036_bib8) 2018; 379
Walker (10.1016/j.ajog.2019.09.036_bib18) 2009; 27
Zhao (10.1016/j.ajog.2019.09.036_bib7) 2017; 27
Park (10.1016/j.ajog.2019.09.036_bib16) 2017; 43
Cao (10.1016/j.ajog.2019.09.036_bib5) 2015; 25
Wang (10.1016/j.ajog.2019.09.036_bib6) 2015; 15
Nevis (10.1016/j.ajog.2019.09.036_bib15) 2017; 11
33036734 - Am J Obstet Gynecol. 2020 Nov;223(5):757
References_xml – volume: 27
  start-page: 1132
  year: 2017
  end-page: 1144
  ident: bib7
  article-title: Laparoscopic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis
  publication-title: J Laparoendosc Adv Surg Tech A
– volume: 104
  start-page: 13
  year: 2007
  end-page: 16
  ident: bib11
  article-title: Total laparoscopic radical hysterectomy: surgical technique and instrumentation
  publication-title: Gynecol Oncol
– volume: 15
  start-page: 928
  year: 2015
  ident: bib6
  article-title: Laparoscopy versus laparotomy for the management of early stage cervical cancer
  publication-title: BMC Cancer
– volume: 138
  start-page: 457
  year: 2015
  end-page: 471
  ident: bib17
  article-title: Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis
  publication-title: Gynecol Oncol
– volume: 13
  year: 2018
  ident: bib14
  article-title: Robotic radical hysterectomy is superior to laparoscopic radical hysterectomy and open radical hysterectomy in the treatment of cervical cancer
  publication-title: PLoS One
– year: 2006
  ident: bib13
  publication-title: National Cancer Institute common terminology criteria for adverse events, version 3.0 (CTCAE)
– volume: 11
  start-page: 1
  year: 2017
  end-page: 16
  ident: bib15
  article-title: Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review
  publication-title: J Robot Surg
– volume: 15
  start-page: 584
  year: 2008
  end-page: 588
  ident: bib9
  article-title: A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer
  publication-title: J Minim Invasive Gynecol
– volume: 25
  start-page: 990
  year: 2015
  end-page: 998
  ident: bib5
  article-title: Prognostic and safety roles in laparoscopic versus abdominal radical hysterectomy in cervical cancer: a meta-analysis
  publication-title: J Laparoendosc Adv Surg Tech A
– volume: 17
  start-page: 64
  year: 2019
  end-page: 84
  ident: bib3
  article-title: Cervical cancer, Version 3.2019, NCCN clinical practice guidelines in oncology
  publication-title: J Natl Compr Canc Netw
– volume: 81
  start-page: 815
  year: 2001
  end-page: 828
  ident: bib4
  article-title: Radical abdominal hysterectomy
  publication-title: Surg Clin North Am
– volume: 44
  start-page: 265
  year: 1974
  end-page: 272
  ident: bib10
  article-title: Five classes of extended hysterectomy for women with cervical cancer
  publication-title: Obstet Gynecol
– volume: 68
  start-page: 394
  year: 2018
  end-page: 424
  ident: bib1
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 69
  start-page: 7
  year: 2019
  end-page: 34
  ident: bib2
  article-title: Cancer statistics, 2019
  publication-title: CA Cancer J Clin
– volume: 43
  start-page: 994
  year: 2017
  end-page: 1002
  ident: bib16
  article-title: Surgical and clinical safety and effectiveness of robot-assisted laparoscopic hysterectomy compared to conventional laparoscopy and laparotomy for cervical cancer: a systematic review and meta-analysis
  publication-title: Eur J Surg Oncol
– volume: 3
  start-page: 224
  year: 2007
  end-page: 228
  ident: bib12
  article-title: Robotic radical hysterectomy in early-stage cervical carcinoma patients, comparing results with total laparoscopic radical hysterectomy cases. The future is now?
  publication-title: Int J Med Robot
– volume: 27
  start-page: 5331
  year: 2009
  end-page: 5336
  ident: bib18
  article-title: Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2
  publication-title: J Clin Oncol
– volume: 379
  start-page: 1895
  year: 2018
  end-page: 1904
  ident: bib8
  article-title: Minimally invasive versus abdominal radical hysterectomy for cervical cancer
  publication-title: N Engl J Med
– volume: 81
  start-page: 815
  year: 2001
  ident: 10.1016/j.ajog.2019.09.036_bib4
  article-title: Radical abdominal hysterectomy
  publication-title: Surg Clin North Am
  doi: 10.1016/S0039-6109(05)70167-5
– volume: 104
  start-page: 13
  issue: suppl1
  year: 2007
  ident: 10.1016/j.ajog.2019.09.036_bib11
  article-title: Total laparoscopic radical hysterectomy: surgical technique and instrumentation
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2006.10.033
– volume: 27
  start-page: 5331
  year: 2009
  ident: 10.1016/j.ajog.2019.09.036_bib18
  article-title: Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.22.3248
– volume: 27
  start-page: 1132
  year: 2017
  ident: 10.1016/j.ajog.2019.09.036_bib7
  article-title: Laparoscopic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis
  publication-title: J Laparoendosc Adv Surg Tech A
  doi: 10.1089/lap.2017.0022
– volume: 43
  start-page: 994
  year: 2017
  ident: 10.1016/j.ajog.2019.09.036_bib16
  article-title: Surgical and clinical safety and effectiveness of robot-assisted laparoscopic hysterectomy compared to conventional laparoscopy and laparotomy for cervical cancer: a systematic review and meta-analysis
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2016.07.017
– volume: 69
  start-page: 7
  year: 2019
  ident: 10.1016/j.ajog.2019.09.036_bib2
  article-title: Cancer statistics, 2019
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21551
– volume: 3
  start-page: 224
  year: 2007
  ident: 10.1016/j.ajog.2019.09.036_bib12
  article-title: Robotic radical hysterectomy in early-stage cervical carcinoma patients, comparing results with total laparoscopic radical hysterectomy cases. The future is now?
  publication-title: Int J Med Robot
  doi: 10.1002/rcs.152
– volume: 68
  start-page: 394
  year: 2018
  ident: 10.1016/j.ajog.2019.09.036_bib1
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21492
– volume: 379
  start-page: 1895
  year: 2018
  ident: 10.1016/j.ajog.2019.09.036_bib8
  article-title: Minimally invasive versus abdominal radical hysterectomy for cervical cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1806395
– volume: 15
  start-page: 584
  year: 2008
  ident: 10.1016/j.ajog.2019.09.036_bib9
  article-title: A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer
  publication-title: J Minim Invasive Gynecol
  doi: 10.1016/j.jmig.2008.06.013
– volume: 138
  start-page: 457
  year: 2015
  ident: 10.1016/j.ajog.2019.09.036_bib17
  article-title: Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2015.06.009
– volume: 11
  start-page: 1
  year: 2017
  ident: 10.1016/j.ajog.2019.09.036_bib15
  article-title: Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review
  publication-title: J Robot Surg
– volume: 15
  start-page: 928
  year: 2015
  ident: 10.1016/j.ajog.2019.09.036_bib6
  article-title: Laparoscopy versus laparotomy for the management of early stage cervical cancer
  publication-title: BMC Cancer
  doi: 10.1186/s12885-015-1818-4
– volume: 13
  year: 2018
  ident: 10.1016/j.ajog.2019.09.036_bib14
  article-title: Robotic radical hysterectomy is superior to laparoscopic radical hysterectomy and open radical hysterectomy in the treatment of cervical cancer
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0193033
– volume: 25
  start-page: 990
  year: 2015
  ident: 10.1016/j.ajog.2019.09.036_bib5
  article-title: Prognostic and safety roles in laparoscopic versus abdominal radical hysterectomy in cervical cancer: a meta-analysis
  publication-title: J Laparoendosc Adv Surg Tech A
  doi: 10.1089/lap.2015.0390
– volume: 44
  start-page: 265
  year: 1974
  ident: 10.1016/j.ajog.2019.09.036_bib10
  article-title: Five classes of extended hysterectomy for women with cervical cancer
  publication-title: Obstet Gynecol
– year: 2006
  ident: 10.1016/j.ajog.2019.09.036_bib13
– volume: 17
  start-page: 64
  year: 2019
  ident: 10.1016/j.ajog.2019.09.036_bib3
  article-title: Cervical cancer, Version 3.2019, NCCN clinical practice guidelines in oncology
  publication-title: J Natl Compr Canc Netw
  doi: 10.6004/jnccn.2019.0001
– reference: 33036734 - Am J Obstet Gynecol. 2020 Nov;223(5):757
SSID ssj0002292
Score 2.6196978
Snippet Standard treatment of early cervical cancer involves a radical hysterectomy and retroperitoneal lymph node dissection. The existing evidence on the incidence...
SourceID unpaywall
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 249.e1
SubjectTerms Adenocarcinoma - pathology
Adenocarcinoma - surgery
Blood Loss, Surgical - statistics & numerical data
Blood Transfusion - statistics & numerical data
Body Mass Index
Carcinoma, Adenosquamous - pathology
Carcinoma, Adenosquamous - surgery
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
cervical cancer
complication
Conversion to Open Surgery - statistics & numerical data
Female
Humans
hysterectomy
Hysterectomy - adverse effects
Hysterectomy - methods
Intraoperative Complications - classification
Intraoperative Complications - epidemiology
LACC
laparoscopic hysterectomy
Laparoscopy
Length of Stay - statistics & numerical data
Lymph Node Excision
Middle Aged
minimally invasive surgery
Operative Time
postoperative adverse event
Postoperative Complications - classification
Postoperative Complications - epidemiology
radical hysterectomy
Risk Factors
robotic hysterectomy
Robotic Surgical Procedures
Uterine Cervical Neoplasms - pathology
Uterine Cervical Neoplasms - surgery
SummonAdditionalLinks – databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwELZGJ4F4YPwaFAEyEm-QrW5i1-FtmjYNpFV7oNJ4smzHhm5pMjXN0PZf8B9zF8cV0sQYUh9S1Zcmype77-zzd4S8T_mo8NrqxEL0SDKZmUT7LEsMpA4TX-ROdhP6x1NxNMu-nPLTDRI70-FEeTNHeYwaiKerIKcPyodBc2D38_Rgugtu9x7ZFBzI94BszqYne98iyYVgK2NJPSAx747zSSKkkP2WmVDdpc_q71jYlQeVU_G3sHSTdj4kD9rqQl_91GX5Ryg63CIncUNPqEA532lXZsde39R3vOtdPiaPelpK9wKOnpANVz0l94_7hfdn5Bf4kdB-lNaeauzi3DjaqT81dF5RVChZwKVewZdLjSXx9LKh2JqLLnW3FER_oGY0-td6gaOoQ2llajtfBT9bhN_yE4X0vy3hpPg3YFsV9WJ-7Qra19SXcNh1GnlOZocHX_ePkr6bQ2IzzlYJdxzIV8Gktb5guTVGe5xEmegUKKXxPHe5E9yhIj4TepIzJ8d2nHuGnbC9SLfJoKor9xLLscbeMj8qgExmmjmditQYwQogc85yPiQsPkxle6lz7LhRqljTdqYQAAoBoEbwScWQfFjbXAShj1tHpxEjKm5hBaerIA7dasXXVj3BCcTln3bvIgwVvP24pKMrV7eNggSSSQlJH4x5EfC5vvqUcSnEaDwkH9eAvcOtvfq_4a_JYLVs3RugZivztn8dfwNAkjfc
  priority: 102
  providerName: Unpaywall
Title Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0002937819311652
https://dx.doi.org/10.1016/j.ajog.2019.09.036
https://www.ncbi.nlm.nih.gov/pubmed/31586602
https://www.proquest.com/docview/2301886756
http://repositorio.inen.pe:8080/handle/INEN/130
UnpaywallVersion publishedVersion
Volume 222
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1097-6868
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002292
  issn: 1085-8709
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect [Accès UNIL ; CHUV ; HEP Vaud ; Sites BCUL]
  customDbUrl:
  eissn: 1097-6868
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002292
  issn: 1085-8709
  databaseCode: ACRLP
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect (Elsevier)
  customDbUrl:
  eissn: 1097-6868
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002292
  issn: 1085-8709
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1097-6868
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002292
  issn: 1085-8709
  databaseCode: AIKHN
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1097-6868
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002292
  issn: 1085-8709
  databaseCode: AKRWK
  dateStart: 19930101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLamTeLyMHHdOmAyEm8QFseXJLxVE1MBreKBSuPJchwbOqVJ1cvQ9sB_4B9zTuIUEGIgpEppU5_UtY_PObY_f4eQZ1zGpTfWRBa8RyQyUUTGCxEVMHVIfZm7rF3QPx2r0US8PZNnW-S4PwuDsMpg-zub3lrrcOcotObRfDrFM74x-KoUXBpHDhm0w0KkmMXg5dcfMI8kyZM-BMbS4eBMh_Ey580nhHflHdep-pNz-j34vE1uruu5ufxiquonh3Ryh-yGSJIOu8reJVuuvkdunIa98vvkGwz9LmMobTw1mHh56WhL2LSk05oiqcgMnnsJHy4MotjpxZJiNi26MO3uDf2MNM_YPM0MS1GHbMjUtuYFvraoMYtXFGbs6woeij8DsnXZzKZXrqQBBl_B2zY5yAMyOXn94XgUhQQMkRWSrSLpJMRLJcus9SXLbVEYj-seqeEQBRZe5i53SjoksWfKpDlzWWKT3DNMXu0Vf0i266Z2-4igSrxlPi4h_hOGOcMVLwrFSoi_nJVyQFjf8toGdnJMklHpHoZ2rrG3NPaWjuHF1YA838jMO26Oa0vzvkN1f-oU7KQG13GtlNxI_aKXf5V72uuMhgGLuzCmds16qWHOx7IM5mlQZq9Tpk3tOZOZUnEyIC822vUPf-3gPyv5iNxKcPmghdQ9Jturxdo9gRhrVRy2g-iQ7AzfvBuN4ToZvx9-_A6QRyhi
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIlF6QDzb5VGMxA1CYzt2Em6oolqg21Mr9WY5jt1ulU1W-yhqD_0P_GNmEmcBVRSElEMensSxx_Owx98Q8kbIuPTGmsiC9oiSLCki45MkKsB1SH2Zu6yd0B8dquFx8uVEnqyRvX4vDIZVBtnfyfRWWoc7u6E1d6fjMe7xjUFXpaDSBGLIgBy-k0ieogf2_vpnnAfnOe9tYCweds50QV7mvDnF-K68AztVf9JON63PTbKxrKfm8pupql800v4Dcj-YkvRjV9uHZM3Vj8jdUVgsf0y-w9jvUobSxlODmZfnjraITXM6rimiikzgvZdwcWEwjJ1ezCmm06Iz0y7f0DPEecb2aSZYijqEQ6a2lS_w2CLLzD5QcNmXFbwUPwO0ddlMxleupCEOvoLTNjvIE3K8_-lobxiFDAyRTSRbRNJJMJhKllnrS5bbojAeJz5SI8AMLLzMXe6UdIhiz5RJc-YybnnuGWav9ko8Jet1U7ttDKHi3jIfl2AAJoY5I5QoCsVKMMCclXJAWN_y2gZ4csySUek-Du1cY29p7C0dwyHUgLxd0Uw7cI5bS4u-Q3W_7RQEpQbdcSuVXFH9xph_pXvd84yGEYvLMKZ2zXKuweljWQaOGpTZ6phpVXvBZKZUzAfk3Yq7_uHXnv1nJV-RjeHR6EAffD78-pzc4ziX0MbXvSDri9nSvQSDa1HstAPqB-hCKEc
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwELZGJ4F4YPwaFAEyEm-QrW5i1-FtmjYNpFV7oNJ4smzHhm5pMjXN0PZf8B9zF8cV0sQYUh9S1Zcmype77-zzd4S8T_mo8NrqxEL0SDKZmUT7LEsMpA4TX-ROdhP6x1NxNMu-nPLTDRI70-FEeTNHeYwaiKerIKcPyodBc2D38_Rgugtu9x7ZFBzI94BszqYne98iyYVgK2NJPSAx747zSSKkkP2WmVDdpc_q71jYlQeVU_G3sHSTdj4kD9rqQl_91GX5Ryg63CIncUNPqEA532lXZsde39R3vOtdPiaPelpK9wKOnpANVz0l94_7hfdn5Bf4kdB-lNaeauzi3DjaqT81dF5RVChZwKVewZdLjSXx9LKh2JqLLnW3FER_oGY0-td6gaOoQ2llajtfBT9bhN_yE4X0vy3hpPg3YFsV9WJ-7Qra19SXcNh1GnlOZocHX_ePkr6bQ2IzzlYJdxzIV8Gktb5guTVGe5xEmegUKKXxPHe5E9yhIj4TepIzJ8d2nHuGnbC9SLfJoKor9xLLscbeMj8qgExmmjmditQYwQogc85yPiQsPkxle6lz7LhRqljTdqYQAAoBoEbwScWQfFjbXAShj1tHpxEjKm5hBaerIA7dasXXVj3BCcTln3bvIgwVvP24pKMrV7eNggSSSQlJH4x5EfC5vvqUcSnEaDwkH9eAvcOtvfq_4a_JYLVs3RugZivztn8dfwNAkjfc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incidence+of+adverse+events+in+minimally+invasive+vs+open+radical+hysterectomy+in+early+cervical+cancer%3A+results+of+a+randomized+controlled+trial&rft.jtitle=American+journal+of+obstetrics+and+gynecology&rft.au=Obermair%2C+Andreas&rft.au=Asher%2C+Rebecca&rft.au=Pareja%2C+Rene&rft.au=Frumovitz%2C+Michael&rft.date=2020-03-01&rft.pub=Elsevier+Inc&rft.issn=0002-9378&rft.eissn=1097-6868&rft.volume=222&rft.issue=3&rft.spage=249.e1&rft.epage=249.e10&rft_id=info:doi/10.1016%2Fj.ajog.2019.09.036&rft.externalDocID=S0002937819311652
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9378&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9378&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9378&client=summon